Literature DB >> 28929799

Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.

Wenlong Li1, Honghao Sun1, Shengtao Xu1, Zheying Zhu2, Jinyi Xu1.   

Abstract

The vital roles of microtubule in mitosis and cell division make it an attractive target for antitumor therapy. Colchicine binding site of tubulin is one of the most important pockets that have been focused on to design tubulin-destabilizing agents. Over the past few years, a large number of colchicine binding site inhibitors (CBSIs) have been developed inspired by natural products or synthetic origins, and many moieties frequently used in these CBSIs are structurally in common. In this review, we will classify the CBSIs into classical CBSIs and nonclassical CBSIs according to their spatial conformations and binding modes with tubulin, and highlight the privileged structures from these CBSIs in the development of tubulin inhibitors targeting the colchicine binding site.

Entities:  

Keywords:  colchicine binding site inhibitors; colchicine domain; microtubule; privileged structures; prodrug; tubulin inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28929799     DOI: 10.4155/fmc-2017-0100

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  29 in total

1.  Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.

Authors:  Kinsie E Arnst; Yuxi Wang; Zi-Ning Lei; Dong-Jin Hwang; Gyanendra Kumar; Dejian Ma; Deanna N Parke; Qiang Chen; Jinliang Yang; Stephen W White; Tiffany N Seagroves; Zhe-Sheng Chen; Duane D Miller; Wei Li
Journal:  Mol Pharmacol       Date:  2019-05-01       Impact factor: 4.436

2.  Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin.

Authors:  Ekaterina S Sazanova; Iuliia A Gracheva; Diane Allegro; Pascale Barbier; Sébastien Combes; Elena V Svirshchevskaya; Alexey Yu Fedorov
Journal:  RSC Med Chem       Date:  2020-06-04

Review 3.  Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents.

Authors:  M Shaheer Malik; Saleh A Ahmed; Ismail I Althagafi; Mohammed Azam Ansari; Ahmed Kamal
Journal:  RSC Med Chem       Date:  2020-01-29

4.  5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.

Authors:  Yuxin Zhuang; Guang Yang; Shaoyu Wu; Jianjun Chen; Jiayin Guo; Dongling Quan; Tingting Zhang; Zichao Yang; Shaobin Tan; Yuheng Ji; Zhipeng Chen; Lin Lv
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 5.  Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.

Authors:  Jiaxing Wang; Duane D Miller; Wei Li
Journal:  Drug Discov Today       Date:  2021-12-08       Impact factor: 7.851

6.  Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents.

Authors:  Paola Oliva; Romeo Romagnoli; Barbara Cacciari; Stefano Manfredini; Chiara Padroni; Andrea Brancale; Salvatore Ferla; Ernest Hamel; Diana Corallo; Sanja Aveic; Noemi Milan; Elena Mariotto; Giampietro Viola; Roberta Bortolozzi
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

7.  Discovery of Novel 4-Arylisochromenes as Anticancer Agents Inhibiting Tubulin Polymerization.

Authors:  Wenlong Li; Wen Shuai; Feijie Xu; Honghao Sun; Shengtao Xu; Hong Yao; Jie Liu; Hequan Yao; Zheying Zhu; Jinyi Xu
Journal:  ACS Med Chem Lett       Date:  2018-09-25       Impact factor: 4.345

8.  Sertaconazole induced toxicity in HeLa cells through mitotic arrest and inhibition of microtubule assembly.

Authors:  Jomon Sebastian; Krishnan Rathinasamy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-23       Impact factor: 3.000

9.  29th Annual GP2A Medicinal Chemistry Conference.

Authors:  Jean-Jacques Helesbeux; Laura Carro; Florence O McCarthy; Vânia M Moreira; Francesca Giuntini; Niamh O'Boyle; Susan E Matthews; Gülşah Bayraktar; Samuel Bertrand; Christophe Rochais; Pascal Marchand
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-07

Review 10.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.